 Imara Inc. IMRA, a clinical-stage biopharmaceutical company dedicated to developing and commercializing novel therapeutics to treat patients suffering from rare inherited genetic disorders of hemoglobin, announced today the appointment of Stephen M. Migausky as Senior Vice President, Legal and General Counsel. In this new role, Mr. Migausky will lead the Companys legal organization, including corporate governance and compliance functions. As we continue to grow, prepare for later stage clinical trials, bolster the pipeline, and transition to a publicly-traded company, Steves expertise as a senior legal counselor will greatly benefit Imara both strategically and tactically, said Rahul Ballal, Ph.D., President and Chief Executive Officer of Imara. 